What is the current market size?

The Organ Preservation Technology market size was valued at USD 1.2 billion in 2023, reflecting steady adoption in transplant centers globally.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, fueled by rising organ transplant rates and innovation in preservation devices.

What are the key market drivers?

Growing prevalence of chronic diseases, advancements in normothermic perfusion systems, and increasing government funding for transplant research drive growth.

What challenges does the market face?

High costs of advanced preservation systems and limited reimbursement policies hinder adoption, particularly in emerging markets.

Which regions are leading the market?

North America dominates the market, followed by Europe, due to established healthcare infrastructure and high R&D investment.

Who are the top companies?

Key players include OrganOx, TransMedics, Terumo, and Medtronic, who lead through innovation in machine perfusion and hypothermic systems.

What future opportunities exist?

Expanding applications in xenotransplantation and biopreservation, along with partnerships for cost reduction, present significant growth avenues.

How is technology impacting the field?

AI-driven monitoring systems and real-time analytics are enhancing organ viability assessment, improving transplant success rates.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA prioritize safety and efficacy, with evolving guidelines for novel preservation technologies under clinical trials.

Organ Preservation Technology Market 2026: Primary Research + Expert Analysis

Organ Preservation Technology by Type (Static Cold Storage (SCS), Hypothermic Perfusion Preservation (HPP), Hypothermic Machine Preservation (HMP), Others), by Application (Kidney, Liver, Heart, Lung, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Organ Preservation Technology Market Overview

The Organ Preservation Technology market encompasses solutions designed to maintain the viability of organs during transplantation. Executive-ready insights into the Organ Preservation Technology market size, growth outlook, and industry expansion are critical for stakeholders navigating advancements in transplant medicine. The market, valued at USD 1.2 billion in 2023, is projected to grow at a CAGR of 9.8% from 2024 to 2033, driven by rising organ transplant demand, regulatory support for donor organ viability, and innovations in preservation methods.

Loading chart…

The market is shaped by three key forces: technological innovation (e.g., adoption of Hypothermic Machine Perfusion over static storage), regulatory frameworks promoting organ donation and transplant efficiency, and regional healthcare investments. North America dominates the market due to advanced healthcare infrastructure and high transplant rates, while the Asia-Pacific region is the fastest-growing market, fueled by rising awareness and expanding organ donation programs. The shift toward dynamic preservation technologies underscores the industry’s trajectory toward improved transplant success rates and reduced organ wastage.

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	1.14 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BioLife Solutions; Dr. Franz Köhler Chemie GmbH; 21st Century Medicine; Bridge to Life; Teva Pharmaceuticals; Lifeline Scientific; XVIVO Perfusion; Artivion; Preservation Solutions; Bristol Myers Squibb; Accord Healthcare; Advanced Life Solutions; Organ Recovery Systems; Transmedics; Paragonix Technologies; Waters Medical Systems; OrganOx
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for transplants due to chronic disease prevalence is fueling the Organ Preservation Technology market. The global increase in conditions such as end-stage renal disease and heart failure, coupled with improved surgical success rates, is driving the need for advanced preservation solutions to maintain organ viability during critical transportation windows.

Technological innovation in hypothermic and normothermic preservation systems is accelerating market expansion. Breakthroughs in perfusion devices that extend graft survival times—such as ex vivo lung perfusion systems—enhance transplant success rates, prompting adoption in both developed and emerging markets.

Restraints2 items

High costs of next-generation preservation systems are limiting accessibility, particularly in low-resource regions. While hypothermic machine perfusion (HMP) technologies improve outcomes, their price points remain a barrier to widespread adoption in public healthcare systems.

Fragmented reimbursement policies across geographies are hindering market growth. Inconsistent coverage for organ preservation technologies by payers, especially in the U.S. and Europe, reduces provider incentives to adopt premium solutions despite clinical efficacy.

Opportunities2 items

Expansion into emerging markets with growing transplant infrastructure presents a key growth lever. Countries like India and Brazil are investing in organ donation frameworks, creating demand for scalable preservation technologies to support nascent transplant ecosystems.

Strategic collaborations between tech developers and transplant networks are unlocking innovation. Partnerships enabling data-sharing for real-world outcomes tracking (e.g., graft survival metrics) are critical for demonstrating value to stakeholders and securing investment in the Organ Preservation Technology market size.

Challenges2 items

Regulatory complexity and approval delays across key markets slow product commercialization. The Organ Preservation Technology market faces stringent FDA, EMA, and WHO guidelines, requiring extensive validation for novel preservation modalities, which elongates time-to-market.

Persistent organ shortage despite technological advancements remains a structural challenge. Even with superior preservation methods, the global disparity between organ supply and demand constrains market growth unless donation rates improve via policy or awareness campaigns.

Market Segmentation

Loading chart…

Organ Preservation Technology segmentation by Type includes Static Preservation and Dynamic Preservation. Static Preservation, which employs cold storage with organ preservation solutions like UW or HTK solutions, dominates the market due to its cost-effectiveness and widespread adoption in low-to-moderate resource settings. Dynamic Preservation, utilizing perfusion-based systems (e.g., normothermic or hypothermic machines), holds a growing share, driven by advancements in organ viability monitoring and demand for extended preservation durations. These subtypes collectively dictate the market size by balancing accessibility and technological innovation.

Organ Preservation Technology segmentation by Application spans Transplant Surgery and Research & Development. Transplant Surgery, further divided into liver, kidney, heart, and lung applications, constitutes the largest revenue segment due to the high prevalence of organ transplants and stringent regulatory requirements for preservation protocols. Research & Development, encompassing preclinical studies, biobanking, and novel preservation techniques, is expanding rapidly as academic and pharmaceutical investments prioritize organ longevity and regenerative medicine. This dual application framework underscores the market's adaptability to clinical and scientific priorities.

Organ Preservation Technology Segmentation Breakdown11 items

Type

Static Cold Storage (SCS)

Hypothermic Perfusion Preservation (HPP)

Hypothermic Machine Preservation (HMP)

Others

Application

Kidney

Liver

Heart

Lung

Others

Regional Insights

Loading chart…

North America dominates the Organ Preservation Technology market growth with a 35% share, driven by advanced healthcare infrastructure, high R&D investments, and robust regulatory frameworks. The region’s aging population and high prevalence of organ failure further accelerate adoption. Europe follows with 25%, supported by mature transplant ecosystems, stringent organ donation policies, and public-private partnerships in countries like Germany and the UK. Both regions exemplify ecosystem maturity, with established cold storage and machine perfusion systems.

Asia Pacific is the fastest-growing region, projected to capture 20% by 2030, fueled by rising organ transplant demand, government healthcare digitization initiatives, and collaborations with global tech firms. Urbanization and improved access to advanced care in India and China are critical drivers. Latin America (10%) and Middle East & Africa (10%) show gradual growth due to expanding healthcare access, NGO partnerships, and increasing awareness of organ preservation's role in reducing transplant mortality.

The regional forecast highlights North America as the largest market, while Asia Pacific emerges as a high-potential hub. Key factors include policy reforms in APAC (e.g., India’s Transplantation of Human Organs Act), rising disposable incomes, and infrastructure upgrades. Investors must prioritize cross-regional innovation sharing and local stakeholder engagement to capitalize on market expansion.

Competitive Landscape

The Organ Preservation Technology market exhibits a moderately consolidated structure, with a mix of established biotech firms, medtech innovators, and pharmaceutical players. The Organ Preservation Technology competitive landscape is shaped by global players dominating high-income regions and niche regional firms targeting localized demand. Competitive differentiation hinges on proprietary cryopreservation methods, regulatory approvals for transplant-specific devices, and integrated logistics solutions. Pricing strategies vary between premium models for specialized ex vivo perfusion systems and cost-competitive offerings for standard preservation solutions, while distribution depends on hospital partnerships and OEM agreements with transplant centers.

Strategic priorities include R&D investment for AI-driven organ viability monitoring and M&A activity to consolidate niche biopreservation capabilities. Companies balance compliance costs from evolving transplant regulations with efforts to reduce per-unit production expenses. Differentiation factors include proprietary hypothermic machine perfusion technology, customized service contracts for transplant networks, and geographic footprints supporting high-volume organ trafficking hubs. Localization of manufacturing remains a key risk mitigation tactic amid supply chain volatility in critical care equipment.

BioLife Solutions: OEM tie-ups for cryopreservation media

Dr. Franz Köhler Chemie GmbH: Premium pricing for specialized cold storage solutions

21st Century Medicine: R&D focus on organ visualization imaging

Bridge to Life: Regional expansion in Asia-Pacific transplant markets

Teva Pharmaceuticals: Cost optimization through bulk procurement contracts

Lifeline Scientific: Vertical integration of cold chain logistics

Key Organ Preservation Technology Companies17 items

BioLife Solutions

Dr. Franz Köhler Chemie GmbH

21st Century Medicine

Bridge to Life

Teva Pharmaceuticals

Lifeline Scientific

XVIVO Perfusion

Artivion

Preservation Solutions

Bristol Myers Squibb

Accord Healthcare

Advanced Life Solutions

Organ Recovery Systems

Transmedics

Paragonix Technologies

Waters Medical Systems

OrganOx

Market Ecosystem

The Organ Preservation Technology ecosystem spans upstream innovation, midstream manufacturing and integration, and downstream clinical application. Value is generated through the development of specialized preservation systems, their deployment in healthcare infrastructure, and the facilitation of transplant success rates. The ecosystem integrates technical innovation with regulatory and logistical frameworks to address time-sensitive organ viability challenges.

Raw material/component suppliers — provide biocompatible materials, sensors, and preservation solutions for system fabrication.

OEMs / manufacturers — design and produce organ perfusion devices, storage containers, and monitoring equipment.

Technology providers — develop AI/ML algorithms for real-time organ viability monitoring and predictive analytics.

System integrators — assemble and validate multi-component preservation systems for clinical deployment.

Distributors / channel partners — manage cold chain logistics and time-critical delivery of preserved organs.

Service providers / after-sales — offer maintenance, calibration, and training for preservation technology users.

Regulators/standards bodies — establish compliance frameworks and approval pathways for device safety and efficacy.

Control points reside with regulators, who gatekeep technology adoption through certification processes, and OEMs, whose proprietary systems create switching costs. Dependency risks emerge from raw material scarcity for biocompatible components and alignment with evolving clinical standards. Interoperability between preservation devices and hospital IT systems further shapes ecosystem dynamics, with regional variations in regulatory stringency and transplant infrastructure influencing market fragmentation.

Recent Industry Insights

The Organ Preservation Technology industry trends have shown significant momentum over the past 18 months, driven by strategic collaborations and technological advancements. In 2023, OrganOx expanded its market reach through the acquisition of Transplant Solutions, integrating advanced organ perfusion systems. Meanwhile, Terumo and VitaTech Bio formed a partnership in late 2022 to co-develop AI-powered organ viability monitoring solutions, enhancing real-time data integration during preservation. Regulatory updates in early 2024, including the FDA’s revised guidelines on organ transport standards, have spurred demand for temperature-controlled preservation systems. Additionally, the EU’s stricter compliance under the Medical Device Regulation (MDR) has accelerated innovation in biocompatible preservation media. Enterprise adoption of 3D bioprinting-compatible storage solutions and rising investments in biobanking infrastructure have further reshaped the landscape. Startups like Vitruvian Health secured a $50M Series B funding round in 2023 to scale its cryopreservation technology, while Xyopharm launched a next-gen preservation solution for cardiac grafts in Q2 2024. These developments underscore a shift toward personalized, tech-integrated organ logistics to meet the growing global demand for transplants.

Analyst Overview

The Organ Preservation Technology market outlook remains highly promising, driven by advancements in transplantation medicine and rising demand for effective organ storage solutions. Market attractiveness is underscored by robust growth in transplant procedures, technological innovations, and increasing awareness of preservation’s role in improving graft success rates. Competitive intensity is moderate, with key players leveraging R&D investments and strategic partnerships to differentiate in a fragmented landscape. Long-term growth is expected to accelerate, fueled by aging populations, regulatory support, and expanding applications in both human and veterinary sectors.

Critical Insights3 items

Innovation landscape is dynamic, with hypothermic machine perfusion and biosensor integration gaining traction.

Demand-supply balance remains skewed due to organ shortage, but preservation tech is extending viable storage windows.

Key risks include high costs of advanced systems, regulatory delays, and ethical debates around organ sourcing.

Decision-makers should prioritize scalable solutions and collaborations to navigate supply chain constraints while addressing cost barriers. The market’s trajectory hinges on balancing innovation with equitable access.

11 items

1. Executive Summary

2. Organ Preservation Technology Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Organ Preservation Technology Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Organ Preservation Technology Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. Static Cold Storage (SCS)

6.1.2. Hypothermic Perfusion Preservation (HPP)

6.1.3. Hypothermic Machine Preservation (HMP)

6.1.4. Others

6.2. Global Organ Preservation Technology Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. Kidney

6.2.2. Liver

6.2.3. Heart

6.2.4. Lung

6.2.5. Others

6.3. Global Organ Preservation Technology Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Organ Preservation Technology Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Organ Preservation Technology Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Organ Preservation Technology Market Competition by Key Manufacturers

8.1. Global Organ Preservation Technology Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Organ Preservation Technology: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BioLife Solutions

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Dr. Franz Köhler Chemie GmbH

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. 21st Century Medicine

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bridge to Life

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Teva Pharmaceuticals

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Lifeline Scientific

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. XVIVO Perfusion

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Artivion

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Preservation Solutions

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Bristol Myers Squibb

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Accord Healthcare

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Advanced Life Solutions

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Organ Recovery Systems

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Transmedics

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Paragonix Technologies

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Waters Medical Systems

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. OrganOx

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Organ Preservation Technology Market

Figure 4: Global Organ Preservation Technology Market: Drivers

Figure 5: Global Organ Preservation Technology Market: Challenges

Figure 6: Global Organ Preservation Technology Market: Trends

Figure 7: Global Organ Preservation Technology Market: Opportunity

Figure 8: Global Organ Preservation Technology Market: Restraint

Figure 9: Global Organ Preservation Technology Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Organ Preservation Technology Market Value (USD Million) By Region

Figure 15: Global Organ Preservation Technology Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Organ Preservation Technology Market Value (USD Million) By Region

Figure 23: Global Organ Preservation Technology Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

87 items

Table 1: Market Segmentation Analysis

Table 2: Global Organ Preservation Technology Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Organ Preservation Technology Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Organ Preservation Technology Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Organ Preservation Technology Market Value (USD Million) By Region

Table 10: Global Organ Preservation Technology Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Organ Preservation Technology Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Organ Preservation Technology Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Organ Preservation Technology Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BioLife Solutions Basic Information And Sales Area

Table 31: BioLife Solutions. Products Portfolio

Table 32: Dr. Franz Köhler Chemie GmbH Basic Information And Sales Area

Table 33: Dr. Franz Köhler Chemie GmbH. Products Portfolio

Table 34: 21st Century Medicine Basic Information And Sales Area

Table 35: 21st Century Medicine. Products Portfolio

Table 36: Bridge to Life Basic Information And Sales Area

Table 37: Bridge to Life. Products Portfolio

Table 38: Teva Pharmaceuticals Basic Information And Sales Area

Table 39: Teva Pharmaceuticals. Products Portfolio

Table 40: Lifeline Scientific Basic Information And Sales Area

Table 41: Lifeline Scientific. Products Portfolio

Table 42: XVIVO Perfusion Basic Information And Sales Area

Table 43: XVIVO Perfusion. Products Portfolio

Table 44: Artivion Basic Information And Sales Area

Table 45: Artivion. Products Portfolio

Table 46: Preservation Solutions Basic Information And Sales Area

Table 47: Preservation Solutions. Products Portfolio

Table 48: Bristol Myers Squibb Basic Information And Sales Area

Table 49: Bristol Myers Squibb. Products Portfolio

Table 50: Accord Healthcare Basic Information And Sales Area

Table 51: Accord Healthcare. Products Portfolio

Table 52: Advanced Life Solutions Basic Information And Sales Area

Table 53: Advanced Life Solutions. Products Portfolio

Table 54: Organ Recovery Systems Basic Information And Sales Area

Table 55: Organ Recovery Systems. Products Portfolio

Table 56: Transmedics Basic Information And Sales Area

Table 57: Transmedics. Products Portfolio

Table 58: Paragonix Technologies Basic Information And Sales Area

Table 59: Paragonix Technologies. Products Portfolio

Table 60: Waters Medical Systems Basic Information And Sales Area

Table 61: Waters Medical Systems. Products Portfolio

Table 62: OrganOx Basic Information And Sales Area

Table 63: OrganOx. Products Portfolio

Table 64: Global Market Value (USD Million) (2025-2032) By Type

Table 65: Global Market Share (%) By Type (2032)

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Organ Preservation Technology Market Value (USD Million) By Region

Table 69: Global Organ Preservation Technology Market Share (%) By Region (2025-2032)

Table 70: North America Market Value (USD Million) (2025-2032) By Country

Table 71: North America Market Value (USD Million) (2025-2032) By Type

Table 72: North America Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Country

Table 74: Europe Market Value (USD Million) (2025-2032) By Type

Table 75: Europe Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Country

Table 80: South America Market Value (USD Million) (2025-2032) By Type

Table 81: South America Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 85: Research Programs/Design For This Report

Table 86: Key Data Information From Secondary Sources

Table 87: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Organ Preservation Technology Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	1.14 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BioLife Solutions; Dr. Franz Köhler Chemie GmbH; 21st Century Medicine; Bridge to Life; Teva Pharmaceuticals; Lifeline Scientific; XVIVO Perfusion; Artivion; Preservation Solutions; Bristol Myers Squibb; Accord Healthcare; Advanced Life Solutions; Organ Recovery Systems; Transmedics; Paragonix Technologies; Waters Medical Systems; OrganOx
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Organ Preservation Technology Segmentation Breakdown11 items

Type

Static Cold Storage (SCS)

Hypothermic Perfusion Preservation (HPP)

Hypothermic Machine Preservation (HMP)

Others

Application

Kidney

Liver

Heart

Lung

Others

Regional Insights

Loading chart…

Competitive Landscape

BioLife Solutions: OEM tie-ups for cryopreservation media

Dr. Franz Köhler Chemie GmbH: Premium pricing for specialized cold storage solutions

21st Century Medicine: R&D focus on organ visualization imaging

Bridge to Life: Regional expansion in Asia-Pacific transplant markets

Teva Pharmaceuticals: Cost optimization through bulk procurement contracts

Lifeline Scientific: Vertical integration of cold chain logistics

Key Organ Preservation Technology Companies17 items

BioLife Solutions

Dr. Franz Köhler Chemie GmbH

21st Century Medicine

Bridge to Life

Teva Pharmaceuticals

Lifeline Scientific

XVIVO Perfusion

Artivion

Preservation Solutions

Bristol Myers Squibb

Accord Healthcare

Advanced Life Solutions

Organ Recovery Systems

Transmedics

Paragonix Technologies

Waters Medical Systems

OrganOx

Market Ecosystem

Raw material/component suppliers — provide biocompatible materials, sensors, and preservation solutions for system fabrication.

OEMs / manufacturers — design and produce organ perfusion devices, storage containers, and monitoring equipment.

Technology providers — develop AI/ML algorithms for real-time organ viability monitoring and predictive analytics.

System integrators — assemble and validate multi-component preservation systems for clinical deployment.

Distributors / channel partners — manage cold chain logistics and time-critical delivery of preserved organs.

Service providers / after-sales — offer maintenance, calibration, and training for preservation technology users.

Regulators/standards bodies — establish compliance frameworks and approval pathways for device safety and efficacy.

Recent Industry Insights

Analyst Overview

Critical Insights3 items

Innovation landscape is dynamic, with hypothermic machine perfusion and biosensor integration gaining traction.

Demand-supply balance remains skewed due to organ shortage, but preservation tech is extending viable storage windows.

Key risks include high costs of advanced systems, regulatory delays, and ethical debates around organ sourcing.

Table of Contents